Last reviewed · How we verify
Infusion of recipient T regulatory cell
Infusion of recipient T regulatory cell is a Biologic drug developed by Stanford University. It is currently in Phase 1 development.
At a glance
| Generic name | Infusion of recipient T regulatory cell |
|---|---|
| Sponsor | Stanford University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- IS-free Treg HaploHCT (PHASE1)
- Liver Transplantation With Tregs at MGH (PHASE1, PHASE2)
- Cell Therapy for Immunomodulation in Kidney Transplantation (PHASE1, PHASE2)
- Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL (PHASE1, PHASE2)
- Liver Transplantation With Tregs at UCSF (PHASE1, PHASE2)
- Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study) (PHASE1)
- TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation (PHASE1)
- Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Infusion of recipient T regulatory cell CI brief — competitive landscape report
- Infusion of recipient T regulatory cell updates RSS · CI watch RSS
- Stanford University portfolio CI
Frequently asked questions about Infusion of recipient T regulatory cell
What is Infusion of recipient T regulatory cell?
Infusion of recipient T regulatory cell is a Biologic drug developed by Stanford University.
Who makes Infusion of recipient T regulatory cell?
Infusion of recipient T regulatory cell is developed by Stanford University (see full Stanford University pipeline at /company/stanford-university).
What development phase is Infusion of recipient T regulatory cell in?
Infusion of recipient T regulatory cell is in Phase 1.